Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 6,578 Castle Biosciences, Inc. shares (Form 4)

Traded Oct 28, 2026 · Filed Oct 30, 2026

On Oct 28, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 6,578 Castle Biosciences, Inc. shares at an average US$36.42 for US$240K under a trading plan, leaving 38,853 shares. Filed Oct 30, 2026 (Form 4).

Sold
6,578 shares
Price
US$36.42 average (US$35.58 to US$36.62)
Value
US$240K
Holding after
38,853 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 28, 2026Common StockSale1,237US$35.5844,194Direct
Oct 28, 2026Common StockSale5,341US$36.6238,853Direct

Source

Download original · View original at SEC

Related